Log in to your Inderes Free account to see all free content on this page.
Genetic Analysis
0.64 NOK
-3.03 %
Less than 1K followers
GEAN
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genetic Analysis
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.0 | 6.2 | 15.9 | 3.3 | 5.9 | 2.1 | 6.4 | 16.7 |
| EBITDA | -1.9 | -8.7 | -9.5 | -4.2 | 0.5 | -1.8 | -1.6 | -6.1 |
| EBIT | -3.1 | -1.0 | -14.2 | -5.5 | -0.8 | -3.2 | -2.8 | -11.3 |
| EBIT-% | -153.7 % | -15.5 % | -89.5 % | -166.2 % | -14.1 % | -154.6 % | -43.4 % | -67.4 % |
| Profit before taxes | -3.2 | -0.9 | -14.8 | -5.8 | -1.0 | -3.3 | -2.6 | -11.4 |
| Net income | -3.2 | -0.9 | -14.8 | -5.8 | -1.0 | -3.3 | -2.6 | -11.4 |
Login required
This content is only available for logged in users